Skip to main content
SpringerLink
Log in

Neue Triple-Therapie für die Behandlung des Diabetes mellitus Typ 1

New triple therapy for treatment of type 1 diabetes

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Endokrinologie, Diabetologie und klinische Ernährung, Medizinische Klinik Kantonsspital, Münsterlingen Spitalcampus 1, 8596, Münsterlingen, Schweiz

    V. Pavlicek

Authors
  1. V. Pavlicek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Pavlicek.

Ethics declarations

Interessenkonflikt

V. Pavlicek gibt folgende Interessenkonflikte an: Advisory Boards für und Kongressbeiträge von: MSD, Sanofi Aventis, NovoNordisk, AstraZeneca, Boeringer Ingelheim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pavlicek, V. Neue Triple-Therapie für die Behandlung des Diabetes mellitus Typ 1. Diabetologe 12, 506–508 (2016). https://doi.org/10.1007/s11428-016-0150-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-016-0150-1

Search

Navigation